Norges Bank
LEGN icon

Norges Bank’s Legend Biotech LEGN Stock Holding History

Norges Bank’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-23,797
Closed -$735K – 2141
2020
Q3 		$735K Hold
23,797
– – ﹤0.01% 2057
2020
Q2 		$1.01M Buy
+23,797
New +$930K ﹤0.01% 2010

Other funds holding LEGN

VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Norges Bank's LEGN Position: Q4 2020 in Review

Norges Bank sold out of Legend Biotech (LEGN) in Q4 2020, closing a stake of 23,797 shares — an estimated $735K sold.

Norges Bank first reported a position in LEGN in Q2 2020 and held it in 2 quarters. The position peaked at $1.01M in Q2 2020. 61 funds tracked by Wall St. Rank hold LEGN as of Q4 2020.

  • Norges Bank reported no remaining Legend Biotech position as of Q4 2020 after selling out during the quarter.
  • Norges Bank sold 23,797 Legend Biotech shares in Q4 2020, an estimated $735K.
  • Norges Bank first reported a position in Legend Biotech in Q2 2020 and held it in 2 quarters.
  • Norges Bank's Legend Biotech position peaked at $1.01M in Q2 2020.
  • 61 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2020.

Based on Norges Bank's 13F filing for Q4 2020, filed 10 Feb 2021.